Time-resolved fluoroimmunoassay (TR-FIA) (Analytical method)

Go to Analytical method classification
ID34
NameTime-resolved fluoroimmunoassay (TR-FIA)
ClassificationAnalytical methods > Ligand binding assay > Immunoassay

Publications with Time-resolved fluoroimmunoassay (TR-FIA)

TitleFirst authorYear
Validity of protein, retinol, folic acid and n–3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth CohortMikkelsen2006
Plasma enterolactone and risk of prostate cancer in middle-aged Swedish menWallstrom2018
Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancerLumme2016
Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, ChinaAtkinson2016
Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer CohortKo2010
The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genesSonestedt2009
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control studySonestedt2008
Circulating enterolactone and risk of endometrial cancerZeleniuch-Jacquotte2006
Circulating enterolactone and risk of breast cancer: a prospective study in New YorkZeleniuch-Jacquotte2004
Prospective study of plasma enterolactone and prostate cancer risk (Sweden)Stattin2004
Plasma enterolactone and breast cancer incidence by estrogen receptor statusOlsen2004
Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control studyKilkkinen2004
Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control studyKilkkinen2003
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control studyStattin2002
An incident case-referent study on plasma enterolactone and breast cancer riskHulten2002
Serum enterolactone and risk of breast cancer: a case-control study in eastern FinlandPietinen2001
Urinary phytoestrogens and postmenopausal breast cancer riskden Tonkelaar2001
Serum enterolactone levels and the risk of breast cancer in women with palpable cystsBoccardo2004
Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish womenAarestrup2013
Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and womenJohnsen2010

Biomarker data

Measurements of biomarkers by Time-resolved fluoroimmunoassay (TR-FIA)

Concentration values

IDParent IDDepthSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianConverted unitAdjustment typeAdjusted onRegressed onExpressed asPublication

Reproducibility values

IDExcretion IDSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication

Associations of biomarkers measured by Time-resolved fluoroimmunoassay (TR-FIA) and exposures

Correlation values

IDIntake IDExcretion IDSubject groupPopulationCountryCohortIntake Time definitionIntake Assessment methodIntakeIntake detailSupplement intakes included?Intake Arithmetic meanIntake Geometric meanIntake MedianIntake UnitIntake Adjusted onBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailBiomarker Arithmetic meanBiomarker Geometric meanBiomarker MedianBiomarker UnitBiomarker Adjusted onCorrelation sizeCorrelation typeCorrelation valueCorrelation 95% CI lowerCorrelation 95% CI upperCorrelation p-valueSignificant?Measurement adjustmentDeattenuated?CovariatesPublication

Metabolomic associations

IDIntake IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsIntake Assessment methodIntakeIntervention doseBiospecimenAnalytical methodBiomarkerStructural identificationFeature selectionArea under curveSensitivitySpecificityPLS-DA VIPBeta coefficientBeta coefficient p-valueANOVA p-valuePublication

Associations of biomarkers measured by Time-resolved fluoroimmunoassay (TR-FIA) and cancer risk

Cancer associations

IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsNo. of casesNo. of controlsBiospecimenAnalytical methodBiomarkerBiomarker detailCancerStudy designPublication